Finance

Beta
Lists
ZTS:NYSE
Zoetis Inc
$79.52
+2.49%
(+1.93) 1D
$80.00
+0.60% (+0.48)
After hours
Closed: Jun 4, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZTS...
Open
$79.37
High
$81.63
Low
$78.64
Mkt. cap
33.34B
Avg. vol.
8.09M
Volume
7.36M
Dividend
2.67%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
13.17
52-wk high
$171.52
52-wk low
$72.38
EPS
$6.04
Beta
0.75
Shares outstanding
419.23M
No. of employees
14K
Open
$79.37
High
$81.63
Low
$78.64
Mkt. cap
33.34B
Avg. vol.
8.09M
Volume
7.36M
Dividend
2.67%
Quarterly dividend
$0.53
Ex-dividend date
Jul 20, 2026
P/E ratio
13.17
52-wk high
$171.52
52-wk low
$72.38
EPS
$6.04
Beta
0.75
Shares outstanding
419.23M
No. of employees
14K
Analyst outlook
Analyst Ratings
Based on 12 analysts giving stock ratings to ZTS in the past 3 months
Buy
Buy
6
Hold
6
Sell
0
12 month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ZTS in the last 3 months.
Highest
Current $79.52
$150.00 (+88.63%)
Average
$123.56 (+55.38%)
Lowest
$95.00 (+19.47%)
News stories
From sources across the web
Profile
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5K
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorPharmaceutical industry
Websitezoetis.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$1.53 / $1.62
-5.28%miss
Revenue / Est. (USD)
2.26B / 2.30B
-1.70%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.46B
2.40B
2.39B
2.26B
Cost of goods sold
647.00M
682.00M
711.00M
640.00M
Cost of revenue
647.00M
682.00M
711.00M
640.00M
Research and development expenses
172.00M
170.00M
199.00M
180.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
608.00M
572.00M
618.00M
584.00M
Operating expense
813.00M
774.00M
848.00M
795.00M
Total operating expenses
1.46B
1.46B
1.56B
1.44B
Operating income
1.00B
944.00M
828.00M
827.00M
Other non operating income
-1.00M
-
-6.00M
-1.00M
EBT including unusual items
902.00M
887.00M
761.00M
758.00M
EBT excluding unusual items
951.00M
899.00M
780.00M
779.00M
Income tax expense
184.00M
166.00M
158.00M
157.00M
Effective tax rate
20.40%
18.71%
20.76%
20.71%
Other operating expenses
-
-
-
-
Net income
718.00M
721.00M
603.00M
601.00M
Net profit margin
29.19%
30.04%
25.26%
26.57%
Earnings per share
1.76
1.70
1.48
1.53
Interest and investment income
19.00M
26.00M
25.00M
21.00M
Interest expense
-53.00M
-58.00M
-57.00M
-62.00M
Net interest expenses
-34.00M
-32.00M
-32.00M
-41.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.12B
1.07B
903.00M
946.00M
Gain or loss from assets sale
3.00M
-
-
-6.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more